gastric juice is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-06-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic pentadecapeptide | Fifteen amino acids; sequence matches a fragment of a gastric juice protein |
| Molecular formula | C62H98N16O22 | Corresponds to a molecular mass near 1419 Da |
| Primary origin | Fragment of human gastric juice protein BPC | First characterized in the early 1990s |
| Common synonyms | BPC 157; PL 14736; pentadecapeptide BPC 157 | Naming conventions vary across publications |
| Reported stability | Stable in gastric juice during in vitro incubation | Based on laboratory incubation, not clinical data |
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
Comparatively simple devices are often used to apply counterions of increasing gradient to a chromatography column. Counterions such as copper (II) are chosen most often for effectively separating peptides and amino acids through complex formation. A simple device can be used to create a salt gradient. Elution buffer is consistently being drawn from the chamber into the mixing chamber, thereby altering its buffer concentration. Generally, the buffer placed into the chamber is usually of high initial concentration, whereas the buffer placed into the stirred chamber is usually of low concentration. As the high concentration buffer from the left chamber is mixed and drawn into the column, the buffer concentration of the stirred column gradually increase. Altering the shapes of the stirred chamber, as well as of the limit buffer, allows for the production of concave, linear, or convex gradients of counterion. A multitude of different mediums are used for the stationary phase. Among the most common immobilized charged groups used are trimethylaminoethyl (TAM), triethylaminoethyl (TEAE), diethyl-2-hydroxypropylaminoethyl (QAE), aminoethyl (AE), diethylaminoethyl (DEAE), sulpho (S), sulphomethyl (SM), sulphopropyl (SP), carboxy (C), and carboxymethyl (CM). Successful packing of the column is an important aspect of ion chromatography. Stability and efficiency of a final column depends on packing methods, solvent used, and factors that affect mechanical properties of the column.
The main mechanisms of action of IUDs occur before fertilization, by preventing sperm from ever reaching the egg. The specific mechanism for preventing sperm from reaching the egg differs by type of IUD.
===== Advantages ===== Determining the state has a low and constant cost of accessing one flip-flop Changing the state has the constant cost of accessing two flip-flops Easy to design and modify Easy to detect illegal states Takes advantage of an FPGA's abundant flip-flops Using a one-hot implementation typically allows a state machine to run at a faster clock rate than any other encoding of that state machine
== Further reading == Krentz, Benjamin D.; Mulheron, Heidi J.; Semrau, Jeremy D.; DiSpirito, Alan A.; Bandow, Nathan L.; Haft, Daniel H.; Vuilleumier, Stéphane; Murrell, J. Colin; McEllistrem, Marcus T.; Hartsel, Scott C.; Gallagher, Warren H. (30 November 2010). "A Comparison of Methanobactins from Methylosinus trichosporium OB3b and Methylocystis Strain SB2 Predicts Methanobactins Are Synthesized from Diverse Peptide Precursors Modified To Create a Common Core for Binding and Reducing Copper Ions". Biochemistry. 49 (47): 10117–10130. doi:10.1021/bi1014375. PMC 3924600. PMID 20961038. Dalton, edited by J. Colin Murrell, Howard (1992). Methane and Methanol Utilizers. Boston, MA: Springer US. ISBN 1-4899-2338-1. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link) Gribble, volume editor, Gordon W. (2003). Natural production of organohalogen compounds. Berlin: Springer. ISBN 3-540-45293-1. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
*) The Bezirk Karl-Marx-Stadt was named Bezirk Chemnitz for a short period at both the beginning and end of the republic, corresponding with the renaming and reversal of the city Chemnitz. Between 10 May 1953 and 30 May 1990, both the city and Bezirk were named Karl-Marx-Stadt. **) East Berlin was not officially a Bezirk, but from 1961 was provided with the function of one.
Sources: en.wikipedia.org
The rapid development of synthetic dyes in the late nineteenth century stems from the rise of industrial research laboratories in Germany, where firms such as BASF and Hoechst used university-trained chemists, designed new processes, and pioneered breakthroughs in synthetic coloring. With over 10 laboratories established between 1880 and 1890, scientists had formalized research practices and contributed to advances in dye chemistry through organized experimentation and chemical design, and made Germany a global leader in synthetic dye manufacturing. The 20th century was again characterized by increases in scope and scale of chemical production. Pigments like cadmium selenide, manganese blue, molybdenum red, and bismuth vanadate were synthesized. High purity titanium dioxide and zinc oxide were produced for the first time on an industrial scale and introduced synthetic white pigments. The first insoluble organic pigments, the red naphthols, containing neither acid nor basic groups, were produced and sold. Furthermore, the quality of the new dyes increased. Chemist Rene Bohn developed a brilliant blue vat dye, indanthrone, with excellent color fastness in 1901. BASF(Badische Anilin und Soda Fabrik), the largest manufacturer of vat dyes, sold it as Indanthren Blue RS, along with the synthetic indigo they placed on the market in 1897. Allegedly James Morton, a leader in England's textile industry, was out walking when he saw some tapestries he produced using aniline dyes had already faded, despite only recently being put on display.
It was, in fact, nothing like material used by the Romans, but was a "natural cement" made by burning septaria – nodules that are found in certain clay deposits, and that contain both clay minerals and calcium carbonate. The burnt nodules were ground to a fine powder. This product, made into a mortar with sand, set in 5–15 minutes. The success of "Roman cement" led other manufacturers to develop rival products by burning artificial hydraulic lime cements of clay and chalk. Roman cement quickly became popular but was largely replaced by Portland cement in the 1850s.
Lymphatic tissues begin to develop by the end of the fifth week of embryonic development. Lymphatic vessels develop from lymph sacs that arise from developing veins, which are derived from mesoderm. The first lymph sacs to appear are the paired jugular lymph sacs at the junction of the internal jugular and subclavian veins. From the jugular lymph sacs, lymphatic capillary plexuses spread to the thorax, upper limbs, neck, and head. Some of the plexuses enlarge and form lymphatic vessels in their respective regions. Each jugular lymph sac retains at least one connection with its jugular vein, the left one developing into the superior portion of the thoracic duct. The spleen develops from mesenchymal cells between layers of the dorsal mesentery of the stomach. The thymus arises as an outgrowth of the third pharyngeal pouch.
== Clinical signs == Horses with Type 1 PSSM usually appear normal at rest, but show signs of exertional rhabdomyolysis ("tying up") such as shortened stride, stiffness, firm musculature, sweating, pain or reluctance to exercise, when asked to perform light work. While episodes of exertional rhabdomyolysis is one of the most frequent signs associated with affected horses (reported in ~37% of affected animals), other common signs include gait abnormalities, shifting lameness, muscle weakness that may result in an inability to rise, colic-like pain, and muscle fasciculation, atrophy, and/or stiffness (most commonly seen in the semimembranosus, semitendinosus, and longissimus muscles). These clinical signs usually first become apparent when the horse is placed into training as a young animal; however, affected horses will show histological changes consistent with muscle damage at one month of age, and may also show elevations in creatine kinase (CK), an enzyme that elevates with muscle damage. Concurrent illness, such as respiratory or gastrointestinal infection, can lead to elevations in CK and potentially life-threatening rhabdomyolysis, even without exercise. Horses with PSSM often have a persistently elevated CK at rest, which differentiates the disease from recurrent exertional rhabdomyolysis, in which horses have normal CK concentrations between episodes.
=== Environment and sustainability === As global populations rise, food demand is becoming an increasingly important issue. Raising conventional livestock requires resources such as land and water, of which availability is concurrently decreasing. As a result, the ability to meet the needs of the growing population may require alternative sources of quality protein. As the global population rises, there is an increasing demand for animal-based proteins that will require the use of alternative and sustainable sources for pet food as well. Pets play an important role in society, providing companionship and support, and owning pets has been linked to reduced incidence of heart disease, stress and depression. The popularity of pet ownership is increasing, and with this is a trend of humanization. People are increasingly demanding pet food ingredients that they believe are healthy. This creates a competition with the human food chain for quality protein sources. Producing insect protein through other agricultural practices requires considerably less resources than traditional livestock. The production of insects also produces lower greenhouse gases and ammonia than traditional livestock species. Insects also have the ability to feed on organic waste products such as vegetable, restaurant and animal waste, therefore reducing the amount of excess food produced by humans. Insects are very efficient at converting feed into protein, as they require less feed than traditional livestock.
Sources: en.wikipedia.org
Despite the policy of state atheism in East Germany, Christian pastor Christian Führer had regularly met with his congregation at St. Nicholas Church for prayer since 1982. Over the next seven years the church's congregation grew, despite authorities' barricading the adjacent streets, and peaceful candlelit marches took place following its services. The secret police issued death threats and even attacked some of the marchers, but the crowds still continued to gather. On 9 October 1989, the police and army units were given permission to use force against those assembled, but this did not deter the church service and march from taking place, which gathered 70,000 people and in which not a single shot was fired.
=== Dog === Dog is a hulking gorilla-like robot belonging to Alyx Vance, built by her father Eli to provide both companionship and protection. Alyx subsequently upgraded the robot into its current form. Despite its name, Dog is anthropomorphic in appearance. Dog provides support to Freeman during training with the Gravity Gun, and makes appearances several times after.
==== Dependent care flexible spending accounts ==== The annual limit for a dependent care flexible spending account is increased from $5,000 per year (or $2,500 if married filing separately) to $7,500 (or $3,750 if married filing separately).
Encouraged by women in the community, it is primarily intended to protect chastity, deter promiscuity, and offer protection from assault. By 2013, UNICEF in conjunction with the Somali authorities reported that the prevalence rate among 1- to 14-year-old girls in the autonomous northern Puntland and Somaliland regions had dropped to 25% following a social and religious awareness campaign. About 93% of Somalia's male population is also reportedly circumcised. Somalia has one of the lowest HIV infection rates on the continent. This is attributed to the Muslim nature of Somali society and adherence of Somalis to Islamic morals. While the estimated HIV prevalence rate in Somalia in 1987 (the first case report year) was 1% of adults, a 2012 report from UNAIDS says that since 2004, estimates from 0.7% to 1.0% have been assumed. Although healthcare is now largely concentrated in the private sector, the country's public healthcare system is in the process of being rebuilt, and is overseen by the Ministry of Health. The Minister of Health is Qamar Adan Ali. The autonomous Puntland region maintains its own Ministry of Health, as does the Somaliland region in northwestern Somalia.
Sources: en.wikipedia.org
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.
The letters abbreviate body protection compound, the name given to the parent protein isolated from gastric juice. The number is an identifier attached to the specific fragment, not a dose or a description of a chemical property.
The sequence corresponds to a segment of an endogenous gastric protein, but the isolated fifteen-amino-acid peptide is a synthetic construct. Whether the free fragment circulates in humans at measurable levels is not clearly established in the published literature.
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.